![Hunter Jackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Hunter Jackson is the founder.
Dr. Jackson was the founder of NPS Pharmaceuticals, Inc. (1986) and held the title of Chairman & Chief Executive Officer.
Dr. Jackson is also the founder of Navigen, Inc. Dr. Jackson is the Lead Independent Director at Q Therapeutics, Inc. since 2014 and serves as a Director at Fluorinov Pharmaceuticals, Inc. Dr. Jackson earned a doctorate from Yale University and an undergraduate degree from the University of Illinois.
Hunter Jackson active positions
| Companies | Position | Start |
|---|---|---|
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system | Director/Board Member | 19/09/2014 |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
Navigen, Inc.
 Navigen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company | Founder | - |
Former positions of Hunter Jackson
| Companies | Position | End |
|---|---|---|
| NPS PHARMACEUTICALS, INC. | Chief Executive Officer | 11/05/2006 |
Training of Hunter Jackson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluorinov Pharmaceuticals, Inc.
Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company | Health Technology |
- Stock Market
- Insiders
- Hunter Jackson
